Education
About Us
Working with TipRanks
Follow Us
Sihuan Pharmaceutical Holdings Group (HK:0460)
:0460
RESEARCH TOOLSreports
0460 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.50 - HK$1.24
Previous CloseN/A
Volume8.01M
Average Volume (3M)129.76M
Market Cap
HK$10.82B
Enterprise ValueHK$5.19B
Total Cash (Recent Filing)HK$3.63B
Total Debt (Recent Filing)¥942.76M
Price to Earnings (P/E)―
Beta0.91
Next Earnings
Sep 02, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 27, 2024Dividend Yield1.81%
Share Statistics
EPS (TTM)-0.03
Shares Outstanding9,329,999,000
10 Day Avg. Volume167,328,067
30 Day Avg. Volume129,759,290
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.65
Price to Sales (P/S)0.00
P/FCF Ratio-21.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sihuan Pharmaceutical Holdings Group News
PremiumCompany Announcements
Sihuan Pharmaceutical Approves Key Resolutions at AGM
PremiumCompany Announcements
Sihuan Pharmaceutical Announces HK$500 Million Share Repurchase Plan
PremiumCompany Announcements
Sihuan Pharmaceutical Announces HK$500 Million Share Repurchase Plan
PremiumCompany Announcements
Sihuan Pharmaceutical Announces Share Repurchase Amidst Business GrowthOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.78%
Mutual Funds
<0.01% Other Institutional Investors
96.31% Public Companies and
Individual Investors
0460 FAQ
What was Sihuan Pharmaceutical Holdings Group ’s price range in the past 12 months?
Sihuan Pharmaceutical Holdings Group lowest stock price was HK$0.49 and its highest was HK$1.24 in the past 12 months.
What is Sihuan Pharmaceutical Holdings Group ’s market cap?
Sihuan Pharmaceutical Holdings Group ’s market cap is HK$10.82B.
When is Sihuan Pharmaceutical Holdings Group ’s upcoming earnings report date?
Sihuan Pharmaceutical Holdings Group ’s upcoming earnings report date is Sep 02, 2025 which is in 81 days.
How were Sihuan Pharmaceutical Holdings Group ’s earnings last quarter?
Sihuan Pharmaceutical Holdings Group released its earnings results on Mar 28, 2025. The company reported -HK$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.022.
Is Sihuan Pharmaceutical Holdings Group overvalued?
According to Wall Street analysts Sihuan Pharmaceutical Holdings Group ’s price is currently Overvalued.
Does Sihuan Pharmaceutical Holdings Group pay dividends?
Sihuan Pharmaceutical Holdings Group pays a Annually dividend of HK$0.02 which represents an annual dividend yield of 1.81%. See more information on Sihuan Pharmaceutical Holdings Group dividends here
What is Sihuan Pharmaceutical Holdings Group ’s EPS estimate?
Sihuan Pharmaceutical Holdings Group ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sihuan Pharmaceutical Holdings Group have?
Sihuan Pharmaceutical Holdings Group has 9,329,999,000 shares outstanding.
What happened to Sihuan Pharmaceutical Holdings Group ’s price movement after its last earnings report?
Sihuan Pharmaceutical Holdings Group reported an EPS of -HK$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sihuan Pharmaceutical Holdings Group ?
Currently, no hedge funds are holding shares in HK:0460
Sihuan Pharmaceutical Holdings Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
61.29%
12-Months-Change
Fundamentals
Return on Equity
-4.93%
Trailing 12-Months
Asset Growth
-11.29%
Trailing 12-Months
Company Description
Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group (0460) is a leading pharmaceutical company based in China, primarily engaged in the development, manufacturing, and marketing of pharmaceutical products. The company operates in sectors including cardiovascular, central nervous system, metabolism, and anti-infective drugs. Sihuan's core products include a diverse range of patented and generic medicines, as well as active pharmaceutical ingredients (APIs) that cater to a broad spectrum of medical needs.
Technical Analysis
Sino Biopharmaceutical
―
China Resources Pharmaceutical Group Ltd.
―
Livzon Pharmaceutical Group
―
CSPC Pharmaceutical Group
―
China Medical System Holdings
―